TrialDiabetes, obesity & metabolism2025

Fixed dose combination of dapagliflozin, glimepiride and extended-release metformin tablets in patients with type 2 diabetes poorly controlled by metformin and glimepiride: A phase III, open label, randomized clinical study in India.

Rakesh Sahay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.